Expert in Sterilization, Biomaterials, Tissue Banking, Medical Product Development, Polymer Toxicology
Expert has spent four years developing unique osteoconductive and osteoinductive allografts for use in orthopedic and neurosurgery. He has had three patents issued on the processing of tissue, and the sterilization of dead tissue.
Expert has spent 30 years in the management of technical teams who carry out product development for healthcare companies. Technology companies in which he has operated are: absorbable polymers for sutures and drug release, orthop
Expert has ten years of experience in the toxicology of biomaterials used in medical products, devices, and drug containers. He has experience in the preparation of experimental protocols for both in vivo and in vitro toxicity testing. He has also carried out acute, sub-acute, and chronic toxicity tests.
For four years, Expert was the head of Osteotech, Inc.'s research in developing osteoinductive allografts and surgical bone pastes, liquids, and methods of sterilizing tissue products.
Expert's academic training in polymer toxicology and his industrial career in the health care industry caused him to be exposed to a large number of candidate polymers for use in contact with living cells and tissues. He was deeply involved with testing methods for safety tests and
During his four years at Ethicon, Expert studied the rates of absorption and tensile strength loss for absorbable polymers such as Lactide Glycolide copolymers, catgut, and drug release polymers such as monoglycerides.
Throughout his entire career in healthcare products, Expert has been researching the uses of cobalt 60 irradiation, E-beam, steam, and ethylene oxide disinfectants. He is currently researching the use of high-pressure sterilization for those products and materials which cannot have the residuals of a sterilant but must be sterilized.
Expert has used cobalt 60 and electron-beam (E-beam) sterilization in his product development activities since 1962.
Expert is experienced with tissue cultures. He has used USP cytotoxicity testing for biomaterials.
Expert is an expert in toxicity testing including pathology and histochemistry techniques. He has experience in carrying out protocols for wound healing methods such as those described by Dr. Thomas Hunt at the University of California at San Francisco. He also has extensive experience in suture models for wound healing.
In his three years researching and formulating plasticizers for PVC, Expert has had a special focus on the use of non-toxic citric acid esters for medical devices. He also worked with the phthalate esters.
Lifenet Tissue Bank- Virginia Beach, VA:
sterlization, debridement, and demineralization of human tissue processingBob has worked with many confidential law firm motions, depositions and court trialsBob has had many Intota Consulting requests from 1982 to date
Expert may consult nationally and internationally, and is also local to the following cities: Virginia Beach, Virginia - Norfolk, Virginia - Chesapeake, Virginia - Richmond, Virginia - Newport News, Virginia - Hampton, Virginia - Alexandria, Virginia - Portsmouth, Virginia - Suffolk, Virginia - Bowie, Maryland
|Year: 1969||Degree: PhD||Subject:||Institution: Biomaterial Science & Toxicology - University of Texas|
|Year: 1966||Degree: MS||Subject:||Institution: Biomaterial Science & Toxicology - University of Texas|
|Year: 1962||Degree: BS||Subject:||Institution: Chemistry - University of Notre Dame|
|Years: 1997 to Present||Employer: Undisclosed||Title:||Department:||Responsibilities:|
|Years: 1993 to 1997||Employer: Becton-Dickinson||Title: Vice President||Department: Research and Development||Responsibilities:|
|Years: 1989 to 1993||Employer: Osteotech, Inc .||Title: Executive Vice President||Department:||Responsibilities:|
|Years: 1988 to 1989||Employer: Trans/Scitech, Incorporated||Title: President||Department:||Responsibilities:|
|Years: 1979 to 1988||Employer: American Sterilizer Co .||Title: Director||Department: Research & Technology||Responsibilities:|
|Years: 1977 to 1979||Employer: Baxter Travenol Labs, Incorporated||Title: Director of Product Development||Department: Artificial Organs Division||Responsibilities:|
|Years: 1972 to 1977||Employer: Ethicon||Title: Director||Department: Patient CareDivision, Research & Product Development||Responsibilities:|
|Years||Country / Region||Summary|
|Years: 1982 to 1988||Country / Region: Saudi Arabia||Summary: Consulting on the subject of introducing sterilization science into the hospitals|
|Years: 1979 to 1984||Country / Region: Telgte, Germany||Summary: Develop a hollow fiber processing capability for a hollow fiber Kidney Dialzyers facility for Baxter Travenol.|
|Years: 1989 to 1993||Country / Region: Leiden, Netherlands||Summary: Establish tissue processing capabilities in concert with university polymer science cell substrates|
|Years: 1994 to 1997||Country / Region: Southern France||Summary: Worked on a radiation process for etching polymers upon which cells would grow|
|Johnson & Johnson's Patient Care Division's Board of Directors;
Osteotech's Board Of Directors;
Co-owner of AMSCO - Leverage Buy Out
|Awards / Recognition|
|He received the Thomas Edison Award from the State of New Jersey for his invention which was the first osteinductive bone healing paste ever invented|
|Publications and Patents Summary|
|He has 40 patents in medical and agricultural inventions and human tissue science|
|Expert Witness Experience|
| Expert has experience with Personal Injury;
Human Tissue Multiple District Litigation;
Medical Device Failure;
Osteotech Patent Infringement Litigation
Root Cause Analysis
|Training / Seminars|
Product Development PACE;
|Board Member Osteotech;
Divisional Board Member Johnson & Johnson;
Leverage Buy Out Owner -ESOP AMSCO
|Other Relevant Experience|
|Artificial Organs Development;
Allograft Product Development;